Tonix Pharmaceuticals Holding Corp (TNXP) stock has fallen -25.90% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives TNXP stock a score of 9 out of a possible 100.
That rank is influenced by a fundamental score of 0. TNXP stock has a mean target price of 3.25. This means analysts expect the stock to rise 215.53% over the next 12 months. TNXP's rank also includes a short-term technical score of 12. The long-term technical score for TNXP is 14.
What's Happening with TNXP Stock Today
Tonix Pharmaceuticals Holding Corp (TNXP) stock is up 5.61% while the S&P 500 has fallen -0.37% as of 11:44 AM on Friday, Jan 22. TNXP has gained $0.05 from the previous closing price of $0.98 on volume of 21,105,444 shares. Over the past year the S&P 500 has gained 15.43% while TNXP has fallen -25.90%. TNXP lost -$2.50 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Tonix Pharmaceuticals Holding Corp (TNXP) Stock.
